In Brief: Lilly
Executive Summary
Lilly: New York City-based Medicus Public Relations will be responsible for a global public relations campaign for Lilly's Evista (raloxifene) for prevention and treatment of postmenopausal osteoporosis, the company announces April 18. Ongoing Phase III clinical trials were begun in early 1994, and an NDA filing is over a year away...